Compile Data Set for Download or QSAR
Found 121 Enz. Inhib. hit(s) with all data for entry = 50010408
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538576(CHEMBL4634092)copy SMILEScopy InChI
Affinity DataIC50: 0.160nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538560(CHEMBL4640002)copy SMILEScopy InChI
Affinity DataIC50: 0.180nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 0.180nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538572(CHEMBL4649132)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538575(CHEMBL4638458)copy SMILEScopy InChI
Affinity DataIC50: 0.320nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538562(CHEMBL4643330)copy SMILEScopy InChI
Affinity DataIC50: 0.380nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538578(CHEMBL4640729)copy SMILEScopy InChI
Affinity DataIC50: 0.390nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538579(CHEMBL4647217)copy SMILEScopy InChI
Affinity DataIC50: 0.440nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538582(CHEMBL4638998)copy SMILEScopy InChI
Affinity DataIC50: 0.780nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538570(CHEMBL4638573)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538563(CHEMBL4648116)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538564(CHEMBL4641569)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538583(CHEMBL4643112)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538577(CHEMBL4648623)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538567(CHEMBL4633860)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538569(CHEMBL4644317)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538581(CHEMBL4642862)copy SMILEScopy InChI
Affinity DataIC50: 2.40nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538568(CHEMBL4640563)copy SMILEScopy InChI
Affinity DataIC50: 3.40nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538565(CHEMBL4635798)copy SMILEScopy InChI
Affinity DataIC50: 4.60nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538574(CHEMBL4638688)copy SMILEScopy InChI
Affinity DataIC50: 6.60nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538566(CHEMBL4632475)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538556(CHEMBL4646914)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538561(CHEMBL4642308)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538558(CHEMBL4641488)copy SMILEScopy InChI
Affinity DataIC50: 25nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538559(CHEMBL4642553)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538557(CHEMBL4633562)copy SMILEScopy InChI
Affinity DataIC50: 27nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538573(CHEMBL4638960)copy SMILEScopy InChI
Affinity DataIC50: 32nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538554(CHEMBL4643800)copy SMILEScopy InChI
Affinity DataIC50: 43nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538555(CHEMBL4645724)copy SMILEScopy InChI
Affinity DataIC50: 73nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538552(CHEMBL4636266)copy SMILEScopy InChI
Affinity DataIC50: 90nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538553(CHEMBL4643218)copy SMILEScopy InChI
Affinity DataIC50: 130nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538580(CHEMBL4647687)copy SMILEScopy InChI
Affinity DataIC50: 207nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538551(CHEMBL4641037)copy SMILEScopy InChI
Affinity DataIC50: 450nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538550(CHEMBL4641014)copy SMILEScopy InChI
Affinity DataIC50: 930nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 47(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538560(CHEMBL4640002)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of USP47 (unknown origin) by biochemical assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538575(CHEMBL4638458)copy SMILEScopy InChI
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538579(CHEMBL4647217)copy SMILEScopy InChI
Affinity DataIC50: 4.20E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 47(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538557(CHEMBL4633562)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of USP47 (unknown origin) by biochemical assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538549(CHEMBL4641424)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetPotassium voltage-gated channel subfamily H member 2(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538576(CHEMBL4634092)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50270667(CHEMBL4130194)copy SMILEScopy InChI
Affinity DataIC50: 8.20E+3nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 27(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human DAC-tagged USP27X expressed in Escherichia coli assessed as cleavage of KI63-linked di-ubiquitin to mono-ubiquitin using di-ubiqu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 2(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human GST-tagged USP2 isoform 4 expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and R...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 15(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human USP15 isoform 2 expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine11...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 4(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human 6His-tagged USP4 expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 6(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human GST-tagged USP6 CD (529 to 1406 residues) expressed in Sf21 insect cells assessed as cleavage of Ubiquitin-Rhodamine110-glycine t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 8(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human USP8 expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine110-glycine u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetProbable ubiquitin carboxyl-terminal hydrolase FAF-X(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human GST-tagged USP9X CD (1554 to 1995 residues) expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 11(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP11 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
Displayed 1 to 50 (of 121 total ) | Next | Last >>
Jump to: